Found 3 clinical trials
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions (INDEPENDENCE)
The purpose of this Phase 3 study is to evaluate the efficacy and safety of Luspatercept compared with placebo in subjects with myeloproliferative neoplasm (MPN)-associated Myelofibrosis (MF) and anemia on concomitant Janus kinase 2 (JAK2) inhibitor therapy and who require red blood cell count (RBC) transfusions. The study is divided …
- 28 views
- 05 May, 2022
- 124 locations
Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury
background about neurotrophic and neuroprotective effects of this hematopoietic growth factors therapy.
- 0 views
- 26 Jan, 2021
Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients
Using Lithium Carbonate to decrease incidence of neutropenia caused by using chemotherapy regimen in breast cancer patients.
- 0 views
- 25 Mar, 2022